Successful long-term replacement therapy with FXIII concentrate (Fibrogammin® P) for severe congenital factor XIII deficiency: a prospective multicentre study

被引：20

作者：

Dreyfus, M. ^{[1
,2
]}

Barrois, D. ^{[3
]}

Borg, J-Y ^{[4
]}

Claeyssens, S. ^{[5
]}

Torchet, M-F ^{[6
]}

Arnuti, B. ^{[7
]}

Pautard, B. ^{[8
]}

机构：

[1] Hop Bicetre, Serv Hematol Biol, F-94270 Le Kremlin Bicetre, France

[2] AP HP, Fac Med Paris Sud, Paris, France

[3] Cap Sante 49, Angers, France

[4] Hop Charles Nicolle, Hematol Lab, Rouen, France

[5] Hop Purpan, Ctr Reg Hemophiles, Toulouse, France

[6] Hop Necker Enfants Malad, Ctr Traitement Hemophiles, Paris, France

[7] Ctr Hosp Gen, Unite Hemovigilance, Valence, France

[8] Ctr Hosp Univ Nord, Serv Oncohemato Pediat, Ctr Accueil & Traitement Enfants & Adolescents He, Amiens, France

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2011年 / 9卷 / 06期

关键词：

RARE COAGULATION DISORDERS; INTRACRANIAL HEMORRHAGE; PHARMACOKINETICS; PROPHYLAXIS; SAFETY; PLASMA;

D O I：

10.1111/j.1538-7836.2011.04281.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1264 / 1266

页数：3

共 13 条

[1]

ABBONDANZO SL, 1988, AM J PEDIAT HEMATOL, V10, P65

[2] The rare coagulation disorders - review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation [J].

Bolton-Maggs, PHB ;

Perry, DJ ;

Chalmers, EA ;

Parapia, LA ;

Wilde, JT ;

Williams, MD ;

Collins, PW ;

Kitchen, S ;

Dolan, G ;

Mumford, AD .

HAEMOPHILIA, 2004, 10 (05) :593-628

[3]

BRACKMANN HH, 1995, THROMB HAEMOSTASIS, V74, P622

[4] Effectiveness of alternative treatments for reducing potential viral contaminants from plasma-derived products [J].

Chandra, S ;

Groener, A ;

Feldman, F .

THROMBOSIS RESEARCH, 2002, 105 (05) :391-400

[5] Long-term prophylaxis in patients with factor XIII deficiency complicated by intracranial haemorrhage in Iran [J].

Eshghi, P. ;

Mahjour, S. B. ;

Naderi, M. ;

Dehbozorgian, J. ;

Karimi, M. .

HAEMOPHILIA, 2010, 16 (02) :383-385

[6] Factor XIII deficiency [J].

Hsieh, L. ;

Nugent, D. .

HAEMOPHILIA, 2008, 14 (06) :1190-1200

[7] International Registry on Factor XIII Deficiency: A basis formed mostly on European data [J].

Ivaskevicius, Vytautas ;

Seitz, Rainer ;

Kohler, Hans R. ;

Schroeder, Verena ;

Muszbek, Laszlo ;

Ariens, Robert A. S. ;

Seifried, Erhard ;

Oldenburg, Johannes .

THROMBOSIS AND HAEMOSTASIS, 2007, 97 (06) :914-921

[8] Factor XIII Deficiency [J].

Karimi, Mehran ;

Bereczky, Zsuzsanna ;

Cohan, Nader ;

Muszbek, Laszlo .

SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2009, 35 (04) :426-438

[9] Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency [J].

Lovejoy, AE ;

Reynolds, TC ;

Visich, JE ;

Butine, MD ;

Young, G ;

Belvedere, MA ;

Blain, RC ;

Pederson, SM ;

Ishak, LM ;

Nugent, DJ .

BLOOD, 2006, 108 (01) :57-62

[10] Prophylactic therapy with Fibrogammin® P is associated with a decreased incidence of bleeding episodes: a retrospective study [J].

Lusher, J. ;

Pipe, S. W. ;

Alexander, S. ;

Nugent, D. .

HAEMOPHILIA, 2010, 16 (02) :316-321

← 1 2 →